No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹207.38Prev. Close
₹207.38Turnover(Lac.)
₹1,442.54Day's High
₹211Day's Low
₹204.252 Week's High
₹28952 Week's Low
₹108Book Value
₹40.45Face Value
₹1Mkt Cap (₹ Cr.)
6,666.97P/E
4.32EPS
48.21Divi. Yield
06 Jul 2026
12:00 AM
AGM
Announcement Date: 06 Jul, 2026
3 Aug 2026
12:00 AM
Board Meeting
Agenda : Audited Result
16 Jan 2026
12:00 AM
EGM
At the operating level, the EBITDA loss amounted to ₹102.9 Crore, a worsening from a loss of ₹91.4 Crore in the previous fiscal quarter.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 32.45 | 32.45 | 32.45 | 32.45 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,301.13 | -253.07 | 92.4 | 480.32 |
Net Worth | 1,333.58 | -220.62 | 124.85 | 512.77 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 252.95 | 76.81 | 78.25 | 181.02 |
yoy growth (%) | 229.3 | -1.84 | -56.76 | 12.24 |
Raw materials | -18.17 | -23.92 | -26.8 | -25.16 |
As % of sales | 7.18 | 31.14 | 34.25 | 13.89 |
Employee costs | -91.58 | -93.08 | -100.92 | -84.3 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -151.13 | -312.4 | -245.97 | -119.03 |
Depreciation | -10.92 | -9.48 | -8.18 | -8.23 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 59.11 | -68.31 | -89.36 | 46.78 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 229.3 | -1.84 | -56.76 | 12.24 |
Op profit growth | -56.46 | 27.78 | 97.72 | 94.16 |
EBIT growth | -54.64 | 25.98 | 109.73 | 72.79 |
Net profit growth | -51.62 | 58.58 | 65.49 | 70.07 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Gross Sales | 39.15 | 71.77 | 75.55 | 238.78 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 39.15 | 71.77 | 75.55 | 238.78 |
Other Operating Income | 1,840.02 | 0 | 0 | 0 |
Other Income | 10.95 | 1.79 | 29.47 | 10.88 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,942 | 146.19 | 4,65,470.98 | 1,115.14 | 0.82 | 5,641.31 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 8,578.5 | 75.65 | 2,26,630.53 | 891 | 0.35 | 2,974 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,886 | 90.28 | 1,85,157.37 | 492 | 0.69 | 4,073 | 222.76 |
Cipla Ltd CIPLA | 1,463 | 36.02 | 1,18,106.99 | 862.16 | 0.89 | 4,672.12 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,191 | 31.89 | 1,17,705.45 | 1,722 | 0.09 | 3,564.6 | 237.3 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Dilip S Shanghvi
Non-Exec & Non-Independent Dir
Vidhi Shanghvi
Non Executive Director
T Rajamannar
Independent Non Exe. Director
Robert Spiegel
Independent Non Exe. Director
Venkateswarlu Jasti
Independent Non Exe. Director
Rekha Warriar
Company Sec. & Compli. Officer
Kajal Damania
Sun Pharma Advanced Res Centre,
Akota Road Akota,
Gujarat - 390020
Tel: 91-265-2330815/2339257
Website: http://www.sparc.life
Email: secretarial@sparcmail.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product ...
Read More
Reports by Sun Pharma Advanced Research Company Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
